TScan Therapeutics, Inc. - TCRX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Quarter snapshot

Latest / Compare

Q3 2026 · Q2 2026

Value (USD)

Total reported value ($000)

$651.7M

QoQ value delta ($000)

-$48K (-0.01%)

Implied price effect (QoQ)

-0.01%

Total shares

35,630,977

QoQ shares delta

+84 (+0.0%)

Total shares held by funds (by quarter)

Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (TCRX)

Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list

Partial Q3 2026 data: 5 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
DC Funds, LP	617,463	630,000	49.27%
Lynx1 Capital Management LP	7,859	8,019,148	0.91%
BVF INC/IL	5,453	5,564,290	0.14%
BAKER BROS. ADVISORS LP	2,729	2,784,792	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	2,115	2,158,831	0.0%
TWO SIGMA INVESTMENTS, LP	1,910	1,949,604	0.0%
RENAISSANCE TECHNOLOGIES LLC	1,300	1,326,799	0.0%
ACADIAN ASSET MANAGEMENT LLC	1,276	1,305,840	0.0%
Deer Management Co. LLC	1,220	1,245,504	0.15%
MILLENNIUM MANAGEMENT LLC	1,140	1,163,611	0.0%
JACOBS LEVY EQUITY MANAGEMENT, INC	1,028	1,049,806	0.0%
CITADEL ADVISORS LLC	989	1,009,107	0.0%
BlackRock, Inc.	974	994,654	0.0%
BOOTHBAY FUND MANAGEMENT, LLC	756	772,241	0.01%
MARSHALL WACE, LLP	673	687,364	0.0%
GEODE CAPITAL MANAGEMENT, LLC	573	584,811	0.0%
D. E. Shaw & Co., Inc.	537	548,402	0.0%
GSA CAPITAL PARTNERS LLP	537	548,087	0.03%
Kalehua Capital Management LLC	445	454,876	0.32%
VANGUARD FIDUCIARY TRUST CO	356	363,954	0.0%
JANE STREET GROUP, LLC	236	241,493	0.0%
Verdad Advisers, LP	228	232,759	0.22%
STATE STREET CORP	203	207,313	0.0%
MORGAN STANLEY	193	197,891	0.0%
HRT FINANCIAL LP	161	164,601	0.0%